Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
NCT06651177
- Conditions
- Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Gateway Community Services Jacksonville, Florida, United States
- IBIS Behavioral Health Tampa, Florida, United States
- Ruth M. Rothstein CORE Center Chicago, Illinois, United States
- The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States